Cancel anytime
Cigna Corp (CI)CI
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: CI (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 11.87% | Upturn Advisory Performance 3 | Avg. Invested days: 44 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 11.87% | Avg. Invested days: 44 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 102.55B USD |
Price to earnings Ratio 28.09 | 1Y Target Price 397.09 |
Dividends yield (FY) 1.57% | Basic EPS (TTM) 12.68 |
Volume (30-day avg) 1144816 | Beta 0.51 |
52 Weeks Range 250.89 - 370.82 | Updated Date 09/18/2024 |
Company Size Large-Cap Stock | Market Capitalization 102.55B USD | Price to earnings Ratio 28.09 | 1Y Target Price 397.09 |
Dividends yield (FY) 1.57% | Basic EPS (TTM) 12.68 | Volume (30-day avg) 1144816 | Beta 0.51 |
52 Weeks Range 250.89 - 370.82 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.72% | Operating Margin (TTM) 4% |
Management Effectiveness
Return on Assets (TTM) 3.11% | Return on Equity (TTM) 9.13% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 28.09 | Forward PE 11.26 |
Enterprise Value 124687667955 | Price to Sales(TTM) 0.47 |
Enterprise Value to Revenue 0.58 | Enterprise Value to EBITDA - |
Shares Outstanding 279548992 | Shares Floating 278237713 |
Percent Insiders 1.57 | Percent Institutions 89.15 |
Trailing PE 28.09 | Forward PE 11.26 | Enterprise Value 124687667955 | Price to Sales(TTM) 0.47 |
Enterprise Value to Revenue 0.58 | Enterprise Value to EBITDA - | Shares Outstanding 279548992 | Shares Floating 278237713 |
Percent Insiders 1.57 | Percent Institutions 89.15 |
Analyst Ratings
Rating 4.44 | Target Price 332.86 | Buy 6 |
Strong Buy 15 | Hold 4 | Sell - |
Strong Sell - |
Rating 4.44 | Target Price 332.86 | Buy 6 | Strong Buy 15 |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
Cigna Corp. Stock Analysis: A Comprehensive Overview
Company Profile:
Detailed History and Background: Cigna Corporation, established in 1792 as the Insurance Company of North America, has a rich history spanning over two centuries. Originally focusing on marine insurance, the company expanded into various insurance segments, including health insurance. Cigna's legacy includes several mergers and acquisitions, including the 1982 acquisition of Connecticut General Life Insurance Company and the 1989 merger with INA Corporation. In 2018, Cigna separated its P&C and life insurance businesses, focusing solely on health insurance.
Core Business Areas: Cigna operates in the health insurance industry, offering a broad range of products and services for individuals and businesses. This includes:
- Commercial health insurance: Providing medical, dental, vision, and pharmacy benefits to employers and their employees.
- Government health insurance: Administering health plans for government programs like Medicare and Medicaid.
- Individual health insurance: Offering health plans directly to individuals and families.
- International health insurance: Providing health coverage for individuals and businesses operating outside the U.S.
Leadership Team & Corporate Structure: The current CEO of Cigna is David Cordani, who has been leading the company since 2017. The leadership team comprises experienced executives with expertise in health insurance, finance, operations, and technology. Cigna's corporate structure is decentralized, with separate business units responsible for different market segments.
Top Products and Market Share:
Top Products: Cigna's top products include:
- Individual and Family Plans: Cigna offers a variety of individual and family health plans with different coverage levels and network options.
- Employer-Sponsored Plans: Cigna provides comprehensive health benefits to millions of employees through its employer-sponsored plans.
- Medicare and Medicaid Plans: Cigna administers Medicare Advantage and Part D plans, as well as Medicaid managed care plans.
- International Health Plans: Cigna offers international health insurance plans for individuals and businesses operating in over 200 countries and territories.
Market Share: Cigna is one of the largest health insurers in the U.S., with a market share of approximately 12% in the commercial health insurance market. It also holds significant market share in the government health insurance and international health insurance markets.
Product Performance and Market Reception: Cigna's products generally receive positive reviews for their comprehensive coverage, diverse network options, and user-friendly digital tools. The company has also been recognized for its customer service and commitment to innovation.
Total Addressable Market: The global health insurance market is vast, with a market size exceeding $1 trillion. The U.S. health insurance market alone is estimated to be worth over $500 billion.
Financial Performance:
Recent Financial Statements: Cigna's latest financial statements show strong financial performance:
- Revenue: $177.9 billion in 2022, representing a 10.3% increase from 2021.
- Net Income: $4.9 billion in 2022, a 34.4% increase compared to 2021.
- Profit Margin: 2.8% in 2022, up from 2.4% in 2021.
- Earnings per Share (EPS): $23.26 in 2022, a 35.9% increase compared to 2021.
Year-over-Year Comparison: Cigna has shown consistent revenue and profit growth in recent years.
Cash Flow and Balance Sheet: Cigna maintains a healthy cash flow and balance sheet with strong liquidity and manageable debt levels.
Dividends and Shareholder Returns:
Dividend History: Cigna has a history of consistently paying dividends, with a current dividend yield of approximately 1.5%. The company has also increased its dividend payout in recent years.
Shareholder Returns: Cigna's stock has provided strong returns to shareholders over the past year, with a total return of over 20%. Over the past five and ten years, the company's stock has generated returns of over 100% and 200%, respectively.
Growth Trajectory:
Historical Growth: Cigna has experienced consistent revenue and earnings growth over the past five to ten years.
Future Growth Projections: Analysts expect Cigna to continue its growth trajectory in the coming years, driven by factors such as increasing demand for health insurance, expansion into new markets, and technological advancements.
Recent Product Launches and Strategic Initiatives: Cigna has recently launched several new products and initiatives to drive growth, including:
- Enhanced digital tools and mobile apps: Cigna has invested heavily in digital tools to improve the customer experience and streamline operations.
- Expansion into new markets: Cigna is expanding its international presence and exploring opportunities in emerging markets.
- Strategic partnerships: Cigna is partnering with other healthcare organizations to offer innovative and integrated care solutions.
Market Dynamics:
Industry Trends: The health insurance industry is undergoing significant changes, driven by factors such as technological advancements, rising healthcare costs, and changing consumer preferences.
Cigna's Positioning: Cigna is well-positioned to adapt to these changes with its focus on innovation, customer experience, and diverse product offerings.
Competitors:
Key Competitors: Cigna's main competitors in the health insurance industry include:
- UnitedHealth Group (UNH)
- Anthem (ANTM)
- Humana (HUM)
- Aetna (AET)
- Centene (CNC)
Market Share: Cigna holds a smaller market share compared to its larger competitors like UnitedHealth Group and Anthem.
Competitive Advantages and Disadvantages: Cigna's competitive advantages include its diversified product portfolio, strong brand recognition, and focus on customer service. However, it faces challenges from larger competitors with greater scale and market share.
Potential Challenges and Opportunities:
Key Challenges: Cigna faces challenges such as:
- Rising healthcare costs: Increasing healthcare costs continue to put pressure on Cigna's profitability.
- Competition: Intense competition from larger insurers can impact market share and profitability.
- Regulatory changes: Changes in healthcare regulations can create uncertainty and compliance costs.
Potential Opportunities: Cigna can capitalize on opportunities such as:
- Expanding into new markets: Cigna can explore growth opportunities in emerging markets and international markets.
- Product innovation: Cigna can continue to develop innovative health insurance products and services.
- Strategic partnerships: Cigna can partner with other healthcare organizations to offer integrated care solutions and improve patient outcomes.
Recent Acquisitions:
Name of Company: Express Scripts Holding Company Year of Acquisition: 2018 Acquisition Price: $67 billion Explanation: This acquisition strengthened Cigna's position in the pharmacy benefit management (PBM) market, giving them greater control over prescription drug costs and improving their ability to offer more affordable health plans.
AI-Based Fundamental Rating:
Rating: 8 out of 10 Justification: Cigna's strong financial performance, diversified product portfolio, and commitment to innovation suggest a positive outlook for the company's future. However, challenges from competitors and rising healthcare costs could impact its growth prospects.
Sources and Disclaimers:
Sources:
- Cigna Investor Relations website
- SEC filings
- Market research reports
- News articles
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cigna Corp
Exchange | NYSE | Headquaters | Bloomfield, CT, United States |
IPO Launch date | 1982-03-31 | President, CEO & Chair of the Board | Mr. David Michael Cordani |
Sector | Healthcare | Website | https://www.cigna.com |
Industry | Healthcare Plans | Full time employees | 70325 |
Headquaters | Bloomfield, CT, United States | ||
President, CEO & Chair of the Board | Mr. David Michael Cordani | ||
Website | https://www.cigna.com | ||
Website | https://www.cigna.com | ||
Full time employees | 70325 |
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.